Though underlying medical conditions play an important role, many aspects of why COVID-19 severity can differ vastly from one to another has remained unclear.
A new study identifies dozens of genomic variations that may drive hard-to-predict differences in COVID-19 clinical outcomes. According to the work, genomic variants in four genes that are critical to SARS-CoV-2 infection, including the
A new study identifies dozens of genomic variations that may drive hard-to-predict differences in COVID-19 clinical outcomes. According to the work, genomic variants in four genes that are critical to SARS-CoV-2 infection, including the <i>ACE2</i> gene, were targets of natural selection and associated with health conditions seen in COVID-19 patients.